Updates in arterial hypertension management

Portuguese authors delve into the challenges surrounding the enhancement of prevention, detection, and management of Systemic Arterial Hypertension (HTN) in this paper. Emphasizing nonpharmacological interventions as a vital component, the authors explore potential solutions. Lifestyle adjustments, recognized for their efficacy in reducing blood pressure (BP), encompass weight management, a nutritious diet, limited salt intake, regular physical activity, and moderated alcohol consumption. The World Health Organization (WHO) advocates for sodium intake reduction to less than 2 g/day (equivalent to 5 g/day salt) in adults. Recommendations extend to alcohol consumption, urging complete abstinence or limiting intake to ≤2 standard drinks per day, coupled with 2 alcohol-free days weekly. This regimen is anticipated to yield a BP reduction of 3–4 mmHg in systolic BP. Despite the asymptomatic nature of HTN, its substantial disease burden underscores the critical role of routine BP screening.
The paper underlines the pivotal role of pharmacological treatment in HTN management. Guidelines advocate for the initiation of low-dose pharmacotherapy, followed by subsequent up-titration and/or the addition of new drugs based on achieved BP levels and tolerability. Notably, low-dose combinations of antihypertensive agents prove more effective in BP reduction and are better tolerated than high-dose monotherapies, aligning with established HTN management principles.